|
Security
Type
|
Security Class Title
|
Fee
Calculation
Rule
|
Amount
Registered(1)
|
Proposed
Maximum
Offering
Price Per Unit(2)
|
Proposed
Maximum
Aggregate
Offering
Price(2)
|
Fee
Rate
|
Amount of
Registration
Fee(2)
|
|
Equity
|
|
Rule 457(c)
and Rule 457(h)
|
|||||
| Common Stock, par value $0.01 per share |
|||||||
|
– AngioDynamics, Inc. 2020 Equity Incentive Plan
|
1,950,000
|
$13.71
|
$26,734,500
|
$110.20 per $1,000,000 |
$2,946.14
|
||
|
– AngioDynamics, Inc. Employee Stock Purchase Plan
|
1,000,000
|
$13.71
|
$13,710,000
|
$110.20 per $1,000,000 |
$1,510.84
|
||
|
Total Offering Amounts
|
$40,444,500
|
$4,456.98
|
|||||
|
Total Fee Offsets
|
–
|
–
|
|||||
|
Net Fee Due
|
$4,456.98
|
||||||
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an indeterminate number of additional shares of common stock, par value $0.01
per share (the “Common Stock”), of AngioDynamics, Inc. that may become issuable under the AngioDynamics, Inc. 2020 Equity Incentive Plan or the AngioDynamics, Inc. Employee Stock Purchase Plan, as amended, resulting from a stock split,
reverse stock split, stock dividend, combination or reclassification of the Common Stock or any other similar transaction effected without the receipt of consideration which results in an increase in the number of shares of Common Stock.
|
|
(2)
|
Pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, the proposed maximum aggregate offering price and the registration fee are estimated based upon the average of the high and low sale prices of the Common Stock as reported
on NASDAQ on January 4, 2023.
|